Status:
TERMINATED
Fludrocortisone for Sudden Hearing Loss
Lead Sponsor:
Oregon Health and Science University
Conditions:
Hearing Loss, Sensorineural
Eligibility:
All Genders
18-89 years
Phase:
EARLY_PHASE1
Brief Summary
The standard of care treatment of sudden hearing loss uses a type of steroid called glucocorticoid. Examples of glucocorticoids are prednisone, methylprednisolone and dexamethasone. Not everybody reco...
Eligibility Criteria
Inclusion
- Age 18 or older
- Idiopathic sudden sensorineural hearing loss within 3 months
- Failure to recover hearing with glucocorticoid treatment or inability to tolerate glucocorticoid
Exclusion
- Other diagnosis for the sudden hearing loss
- Concurrent systemic use of another steroid
- Hypersensitivity to fludrocortisone
- Systemic fungal infection
- Hypertension requiring two or more medications
- Pitting edema
- Cardiomegaly
- Congestive heart failure
- Electrolyte abnormality
- Concurrent use of barbiturates, phenytoin, fosphenytoin, rifampin, or rifapentine
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01186185
Start Date
August 1 2012
End Date
March 1 2016
Last Update
October 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239